ABBV
AbbVie (ABBV) Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions
AbbVie (NYSE: ABBV) FY 2026 Other Release
AbbVie (ABBV) AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults
AbbVie (NYSE: ABBV) FY 2026 Other Release
AbbVie (ABBV) Sec Form 8K
AbbVie (NYSE: ABBV) Sec Form 8K
AbbVie (ABBV) Allergan Aesthetics Highlights Medical Weight Loss (Mwl) Data And The Changing Profile Of Patients
AbbVie (NYSE: ABBV) FY 2026 Other Release
AbbVie (ABBV) Leerink Partners Global Healthcare Conference
AbbVie (NYSE: ABBV) FY 2026 Corporate Conference
AbbVie (ABBV) AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn’s Disease
AbbVie (NYSE: ABBV) FY 2026 Other Release
AbbVie (ABBV) Sec Form 8K
AbbVie (NYSE: ABBV) Sec Form 8K
AbbVie (ABBV) TD Cowen 46th Annual Health Care Conference
AbbVie (NYSE: ABBV) FY 2026 Corporate Conference
AbbVie (ABBV) AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States
AbbVie (NYSE: ABBV) FY 2026 Other Release
AbbVie (ABBV) Sec Form 10K
AbbVie (NYSE: ABBV) Sec Form 10K